​Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Publication Title

SITC 2021

Document Type

Presentation

Publication Date

2021

Keywords

oregon; washington

Area of Special Interest

Cancer

Area of Special Interest

Women & Children

Specialty/Research Institute

Oncology

This document is currently not available here.


Share

COinS